| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JSO.21053 |
| P698 | PubMed publication ID | 18726889 |
| P2093 | author name string | Dominique Elias | |
| Jesus Esquivel | |||
| Dario Baratti | |||
| Marcello Deraco | |||
| Shigeki Kusamura | |||
| P2860 | cites work | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology | Q33262026 |
| P433 | issue | 4 | |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| colorectal cancer | Q188874 | ||
| P304 | page(s) | 263-267 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination | |
| P478 | volume | 98 |
| Q47821560 | A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma. |
| Q37108203 | A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis |
| Q33995028 | A systematic review of treatment guidelines for metastatic colorectal cancer |
| Q53264117 | Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional study |
| Q48645092 | Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI). |
| Q54967718 | Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons. |
| Q57125908 | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer |
| Q36160064 | Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details |
| Q26768376 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selection |
| Q55036258 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in seven patients with peritoneal sarcomatosis from uterine sarcoma. |
| Q37285937 | Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study. |
| Q35234968 | Cytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy only |
| Q38804709 | Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies |
| Q34251792 | Early and long-term outcomes of patients undergoing liver resection and diaphragm excision for advanced colorectal liver metastases |
| Q55365705 | Early experience with cytoreduction and hyperthermic intraperitoneal chemotherapy at a newly developed center for peritoneal malignancy. |
| Q33777576 | Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin |
| Q44408342 | Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. |
| Q35216296 | Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis |
| Q85333204 | HIPEC: standard of care or an experimental approach? |
| Q44297884 | Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer |
| Q84474546 | Impact of simultaneous diaphragm resection during hepatectomy for treatment of metastatic colorectal cancer |
| Q39014341 | Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review |
| Q84565592 | Is hyperthermic intraoperative peritoneal chemotherapy and systemic chemotherapy as effective as standard intraperitoneal chemotherapy: time for a prospective trial? |
| Q40343261 | Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q54308984 | Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases. |
| Q26849259 | Looking up: Recent advances in understanding and treating peritoneal carcinomatosis |
| Q38166245 | Melphalan: a promising agent in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q46793061 | Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy |
| Q38253190 | Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). |
| Q60912302 | Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study |
| Q35954086 | Oral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings |
| Q26774607 | Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases |
| Q47285140 | Ovarian Metastases of Colorectal Origin: Treatment Patterns and Factors Affecting Outcomes |
| Q26768306 | Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer? |
| Q53408158 | Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases. |
| Q34391090 | Peritoneal carcinomatosis of colorectal origin. |
| Q34366940 | Peritoneal carcinomatosis of gastrointestinal tumors: where are we now? |
| Q37090867 | Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy |
| Q38260594 | Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis. |
| Q85855891 | Preclinical antitumor activity of a nanoparticulate SN38 |
| Q44076876 | Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. |
| Q36758901 | Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). |
| Q40496581 | Prognostic factors of intraperitoneal chemotherapy for peritoneal carcinomatosis of gastric cancer: A retrospective study from a single center |
| Q55688974 | Prognostic factors of peritoneal metastases from colorectal cancer following cytoreductive surgery and perioperative chemotherapy. |
| Q44646347 | Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. |
| Q46924394 | Prophylactic hyperthermic intraperitoneal chemotherapy in patients with epithelial appendiceal neoplasms |
| Q47155878 | Role of Imaging in Peritoneal Surface Malignancies |
| Q37708013 | Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer |
| Q26830444 | Role of surgery in colorectal cancer liver metastases |
| Q41132530 | Selection of patients and staging of peritoneal surface malignancies |
| Q83764549 | Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis |
| Q41828967 | Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection |
| Q92086470 | Systemic chemotherapy plus cetuximab after complete surgery in the treatment of isolated colorectal peritoneal carcinoma: COCHISE phase II clinical trial |
| Q48703777 | The development of a peritoneal surface malignancy program: a tale of three hospitals. |
| Q38027027 | The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC). |
| Q26783662 | Treatment of peritoneal metastases from colorectal cancer |
Search more.